Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2013

Open Access 01-12-2013 | Research article

Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women

Authors: Hector L Lopez, Tim N Ziegenfuss, Jennifer E Hofheins, Scott M Habowski, Shawn M Arent, Joseph P Weir, Arny A Ferrando

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2013

Login to get access

Abstract

Background

Numerous natural products are marketed and sold claiming to decrease body weight and fat, but few undergo finished product-specific research demonstrating their safety and efficacy.

Objective

To determine the safety and efficacy of a multi-ingredient supplement containing primarily raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium (Prograde Metabolism™ [METABO]) as an adjunct to an eight-week weight loss program.

Methods

Using a randomized, placebo-controlled, double-blind design, 70 obese but otherwise healthy subjects were randomly assigned to METABO or a placebo and underwent 8 weeks of daily supplementation, a calorie restricted diet, and exercise training. Subjects were tested for changes in body composition, serum adipocytokines (adiponectin, resistin, leptin, TNF-α, IL-6) and markers of health including heart rate and blood pressure.

Results

Of the 45 subjects who completed the study, significant differences were observed in: body weight (METABO -2.0% vs. placebo -0.5%, P < 0.01), fat mass (METABO -7.8 vs. placebo -2.8%, P < 0.001), lean mass (METABO +3.4% vs. placebo +0.8%, P < 0.03), waist girth (METABO -2.0% vs. placebo -0.2%, P < 0.0007), hip girth (METABO -1.7% vs. placebo -0.4%, P < 0.003), and energy levels per anchored visual analogue scale (VAS) (METABO +29.3% vs. placebo +5.1%, P < 0.04). During the first 4 weeks, effects/trends for maintaining elevated serum leptin (P < 0.03) and decreased serum resistin (P < 0.08) in the METABO group vs. placebo were also observed. No changes in systemic hemodynamics, clinical blood chemistries, adverse events, or dietary intake were noted between groups.

Conclusions

METABO administration is a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. Adherence to the eight-week weight loss program also led to beneficial changes in body fat in placebo. Ongoing studies to confirm these results and clarify the mechanisms (i.e., biochemical and neuroendocrine mediators) by which METABO exerts the observed salutary effects are being conducted.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Finkelstein EA, Trogdon JG, Cohen JW, Dietz W: Annual medical spending attributable to obesity; payer-and service-specific estimates. Health Aff. 2009, 28: w822-w831. 10.1377/hlthaff.28.5.w822.CrossRef Finkelstein EA, Trogdon JG, Cohen JW, Dietz W: Annual medical spending attributable to obesity; payer-and service-specific estimates. Health Aff. 2009, 28: w822-w831. 10.1377/hlthaff.28.5.w822.CrossRef
5.
go back to reference Scarpellini E, Tack J: Obesity and metabolic syndrome: an inflammatory condition. Dig Dis. 2012, 30: 148-153. 10.1159/000336664.CrossRefPubMed Scarpellini E, Tack J: Obesity and metabolic syndrome: an inflammatory condition. Dig Dis. 2012, 30: 148-153. 10.1159/000336664.CrossRefPubMed
7.
go back to reference Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257: 79-83. 10.1006/bbrc.1999.0255.CrossRefPubMed Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257: 79-83. 10.1006/bbrc.1999.0255.CrossRefPubMed
8.
go back to reference Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1619. 10.1161/01.ATV.20.6.1595.CrossRefPubMed Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1619. 10.1161/01.ATV.20.6.1595.CrossRefPubMed
9.
go back to reference Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y, Osaka CAD, Study Group: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003, 23: 85-89. 10.1161/01.ATV.0000048856.22331.50.CrossRefPubMed Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y, Osaka CAD, Study Group: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003, 23: 85-89. 10.1161/01.ATV.0000048856.22331.50.CrossRefPubMed
10.
go back to reference Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003, 42: 231-234. 10.1161/01.HYP.0000083488.67550.B8.CrossRefPubMed Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003, 42: 231-234. 10.1161/01.HYP.0000083488.67550.B8.CrossRefPubMed
11.
go back to reference Trujillo ME, Scherer PE: Adiponectin: Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005, 257: 167-175. 10.1111/j.1365-2796.2004.01426.x.CrossRefPubMed Trujillo ME, Scherer PE: Adiponectin: Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005, 257: 167-175. 10.1111/j.1365-2796.2004.01426.x.CrossRefPubMed
12.
go back to reference Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H: Anti-obese action of raspberry ketone. Life Sci. 2005, 77: 194-204. 10.1016/j.lfs.2004.12.029.CrossRefPubMed Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H: Anti-obese action of raspberry ketone. Life Sci. 2005, 77: 194-204. 10.1016/j.lfs.2004.12.029.CrossRefPubMed
13.
go back to reference Park KS: Raspberry ketone increases both lipolysis and fatty acid oxidation in 3 T3-L1 adipocytes. Planta Med. 2010, 76: 1654-1658. 10.1055/s-0030-1249860.CrossRefPubMed Park KS: Raspberry ketone increases both lipolysis and fatty acid oxidation in 3 T3-L1 adipocytes. Planta Med. 2010, 76: 1654-1658. 10.1055/s-0030-1249860.CrossRefPubMed
14.
go back to reference Diepvens K, Westerterp KR, Westerterp-Plantenga MS: Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R77-R85.CrossRefPubMed Diepvens K, Westerterp KR, Westerterp-Plantenga MS: Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R77-R85.CrossRefPubMed
15.
go back to reference Josse AR, Sherriffs SS, Holwerda AM, Andrews R, Staples AW, Phillips SM: Effects of capsinoid ingestion on energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab. 2010, 7: 65-10.1186/1743-7075-7-65.CrossRef Josse AR, Sherriffs SS, Holwerda AM, Andrews R, Staples AW, Phillips SM: Effects of capsinoid ingestion on energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab. 2010, 7: 65-10.1186/1743-7075-7-65.CrossRef
16.
go back to reference Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M: Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am J Clin Nutr. 2012, 95: 845-850. 10.3945/ajcn.111.018606.CrossRefPubMed Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M: Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am J Clin Nutr. 2012, 95: 845-850. 10.3945/ajcn.111.018606.CrossRefPubMed
17.
go back to reference Bloomer R, Canale R, Shastri S, Suvarnapathki S: Effect of oral intake of caspaicinoid beadlets on catecholamine secretion and blood markers of lipolysis in healthy adult: a randomized, placebo, controlled, double-blind, cross-over study. Lipids Health Dis. 2010, 9: 72-10.1186/1476-511X-9-72.PubMedCentralCrossRefPubMed Bloomer R, Canale R, Shastri S, Suvarnapathki S: Effect of oral intake of caspaicinoid beadlets on catecholamine secretion and blood markers of lipolysis in healthy adult: a randomized, placebo, controlled, double-blind, cross-over study. Lipids Health Dis. 2010, 9: 72-10.1186/1476-511X-9-72.PubMedCentralCrossRefPubMed
18.
go back to reference Okamoto M, Irii H, Tahara Y, Ishii H, Hirao A, Udagawa H, Hiramoto M, Yasuda K, Takanishi A, Shibata S, Shimizu I: Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J Med Chem. 2011, 54: 6295-6304. 10.1021/jm200662c.CrossRefPubMed Okamoto M, Irii H, Tahara Y, Ishii H, Hirao A, Udagawa H, Hiramoto M, Yasuda K, Takanishi A, Shibata S, Shimizu I: Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J Med Chem. 2011, 54: 6295-6304. 10.1021/jm200662c.CrossRefPubMed
19.
go back to reference Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T, Morimitsu Y, Kubota K, Tsuda T: 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3 T3-L1 adipocytes. Biochem Biophys Res Commun. 2008, 373: 429-434. 10.1016/j.bbrc.2008.06.046.CrossRefPubMed Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T, Morimitsu Y, Kubota K, Tsuda T: 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3 T3-L1 adipocytes. Biochem Biophys Res Commun. 2008, 373: 429-434. 10.1016/j.bbrc.2008.06.046.CrossRefPubMed
20.
go back to reference Ban JO, Lee DH, Kim EJ, Kang JW, Kim MS, Cho MC, Jeong HS, Kim JW, Yang Y, Hong JT, Yoon do Y: Antiobesity effects of a sulfur compound thiacremonone mediated via down-regulation of serum triglyceride and glucose levels and lipid accumulation in the liver of db/db mice. Phytother Res. 2012, 26: 1265-1271. 10.1002/ptr.3729.CrossRefPubMed Ban JO, Lee DH, Kim EJ, Kang JW, Kim MS, Cho MC, Jeong HS, Kim JW, Yang Y, Hong JT, Yoon do Y: Antiobesity effects of a sulfur compound thiacremonone mediated via down-regulation of serum triglyceride and glucose levels and lipid accumulation in the liver of db/db mice. Phytother Res. 2012, 26: 1265-1271. 10.1002/ptr.3729.CrossRefPubMed
21.
go back to reference Ernsberger P, Johnson JL, Rosenthal T, Mirelman D, Koletsky RJ: Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens. 2007, 20: 866-874. 10.1016/j.amjhyper.2007.02.015.PubMedCentralCrossRefPubMed Ernsberger P, Johnson JL, Rosenthal T, Mirelman D, Koletsky RJ: Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens. 2007, 20: 866-874. 10.1016/j.amjhyper.2007.02.015.PubMedCentralCrossRefPubMed
22.
go back to reference Stohs SJ, Preuss HG, Shara M: A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012, 9: 527-538. 10.7150/ijms.4446.PubMedCentralCrossRefPubMed Stohs SJ, Preuss HG, Shara M: A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012, 9: 527-538. 10.7150/ijms.4446.PubMedCentralCrossRefPubMed
23.
go back to reference Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990, 51: 241-247.PubMed Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990, 51: 241-247.PubMed
24.
go back to reference Martin CK, O’Neil PM, Tollesfson G, Greenway FL, Marney AW: The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008, 51: 324-326. 10.1016/j.appet.2008.03.002.PubMedCentralCrossRefPubMed Martin CK, O’Neil PM, Tollesfson G, Greenway FL, Marney AW: The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008, 51: 324-326. 10.1016/j.appet.2008.03.002.PubMedCentralCrossRefPubMed
25.
go back to reference Weir JP: Quantifying test-retest reliability using the intraclass correlation coefficient. J Strength Cond Res. 2005, 19: 231-240.PubMed Weir JP: Quantifying test-retest reliability using the intraclass correlation coefficient. J Strength Cond Res. 2005, 19: 231-240.PubMed
26.
go back to reference Lohman T, Martorell R, Roche AF: Anthropometric standardization reference manual. 1988, Champaign, IL: Human Kinetics Books Lohman T, Martorell R, Roche AF: Anthropometric standardization reference manual. 1988, Champaign, IL: Human Kinetics Books
27.
go back to reference Valcour V, Yeh TM, Bartt R, Clifford D, Gerschenson M, Evans SR, Cohen BA, Ebenezer GJ, Hauer P, Millar L, Gould M, Tran P, Shikuma C, Souza S, McArthur JC: AIDS Clinical Trials Group (ACTG) 5157 protocol team. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Med. 2009, 10: 103-110. 10.1111/j.1468-1293.2008.00658.x.PubMedCentralCrossRefPubMed Valcour V, Yeh TM, Bartt R, Clifford D, Gerschenson M, Evans SR, Cohen BA, Ebenezer GJ, Hauer P, Millar L, Gould M, Tran P, Shikuma C, Souza S, McArthur JC: AIDS Clinical Trials Group (ACTG) 5157 protocol team. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Med. 2009, 10: 103-110. 10.1111/j.1468-1293.2008.00658.x.PubMedCentralCrossRefPubMed
28.
go back to reference Campbell WW, Haub MD, Wolfe RR, Ferrando AA, Sullivan DH, Apolzan JW, Iglay HB: Resistance training preserves fat-free mass without impacting changes in protein metabolism after weight loss in older women. Obesity (Silver Spring). 2009, 17: 1332-1339. Campbell WW, Haub MD, Wolfe RR, Ferrando AA, Sullivan DH, Apolzan JW, Iglay HB: Resistance training preserves fat-free mass without impacting changes in protein metabolism after weight loss in older women. Obesity (Silver Spring). 2009, 17: 1332-1339.
29.
go back to reference Hunter GB, Bryne NM, Sirikul B, Fernandez JR, Zuckermann PA, Darnell BE, Gower BA: Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity (Silver Spring). 2008, 16: 1045-1051. 10.1038/oby.2008.38.CrossRef Hunter GB, Bryne NM, Sirikul B, Fernandez JR, Zuckermann PA, Darnell BE, Gower BA: Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity (Silver Spring). 2008, 16: 1045-1051. 10.1038/oby.2008.38.CrossRef
30.
go back to reference Weinheimer EM, Sands LP, Campbell WW: A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass on middle-aged and older adults: implications for sarcopenic obesity. Nutt Rev. 2010, 68: 375-388. 10.1111/j.1753-4887.2010.00298.x.CrossRef Weinheimer EM, Sands LP, Campbell WW: A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass on middle-aged and older adults: implications for sarcopenic obesity. Nutt Rev. 2010, 68: 375-388. 10.1111/j.1753-4887.2010.00298.x.CrossRef
31.
go back to reference Hunter GR, Brock DW, Byrne NM, Chandler-Laney PC, Del Corral P, Gower BA: Exercise training prevents regain of visceral fat for 1 year following weight loss. Obesity (Silver Spring). 2010, 18: 690-695. 10.1038/oby.2009.316.CrossRef Hunter GR, Brock DW, Byrne NM, Chandler-Laney PC, Del Corral P, Gower BA: Exercise training prevents regain of visceral fat for 1 year following weight loss. Obesity (Silver Spring). 2010, 18: 690-695. 10.1038/oby.2009.316.CrossRef
32.
go back to reference Strychar I, Lavoie ME, Messier K, Krelis AD, Doucet E, Prud’homme D, Fontaine J, Rabasa-Lhoret R: Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study. J Am Diet Assoc. 2009, 109: 718-724. 10.1016/j.jada.2008.12.026.CrossRefPubMed Strychar I, Lavoie ME, Messier K, Krelis AD, Doucet E, Prud’homme D, Fontaine J, Rabasa-Lhoret R: Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study. J Am Diet Assoc. 2009, 109: 718-724. 10.1016/j.jada.2008.12.026.CrossRefPubMed
33.
go back to reference Sadashiv Tiwari S, Paul BN, Kumar S, Chandra A, Dhananiai S, Negi MP: Over expression of resistin in adipose tissue of the obese induces insulin resistin. World J Diabetes. 2012, 3: 135-141. 10.4239/wjd.v3.i7.135.CrossRefPubMed Sadashiv Tiwari S, Paul BN, Kumar S, Chandra A, Dhananiai S, Negi MP: Over expression of resistin in adipose tissue of the obese induces insulin resistin. World J Diabetes. 2012, 3: 135-141. 10.4239/wjd.v3.i7.135.CrossRefPubMed
34.
35.
go back to reference Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J: Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci. 2007, 104: 18276-18279. 10.1073/pnas.0706481104.PubMedCentralCrossRefPubMed Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J: Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci. 2007, 104: 18276-18279. 10.1073/pnas.0706481104.PubMedCentralCrossRefPubMed
36.
go back to reference Wang L, Meng X, Zhang F: Raspberry ketone protects rats fed high-fat diets against non-alcoholic steatohepatitis. J Med Food. 2012, 15: 495-503. 10.1089/jmf.2011.1717.PubMedCentralCrossRefPubMed Wang L, Meng X, Zhang F: Raspberry ketone protects rats fed high-fat diets against non-alcoholic steatohepatitis. J Med Food. 2012, 15: 495-503. 10.1089/jmf.2011.1717.PubMedCentralCrossRefPubMed
37.
go back to reference Ludy MJ, Moore GE, Mattes RD: The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans. Chem Senses. 2012, 37: 103-121. 10.1093/chemse/bjr100.PubMedCentralCrossRefPubMed Ludy MJ, Moore GE, Mattes RD: The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans. Chem Senses. 2012, 37: 103-121. 10.1093/chemse/bjr100.PubMedCentralCrossRefPubMed
38.
go back to reference Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M: Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009, 89: 45-50.PubMedCentralCrossRefPubMed Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M: Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009, 89: 45-50.PubMedCentralCrossRefPubMed
39.
go back to reference Whiting S, Derbyshire E, Tiwari BK: Capsaicinoids and capsinoids. A potential role for weight management? A systematic review of the evidence. Appetite. 2012, 59: 341-348. 10.1016/j.appet.2012.05.015.CrossRefPubMed Whiting S, Derbyshire E, Tiwari BK: Capsaicinoids and capsinoids. A potential role for weight management? A systematic review of the evidence. Appetite. 2012, 59: 341-348. 10.1016/j.appet.2012.05.015.CrossRefPubMed
40.
go back to reference Carpéné C, Galitzky J, Fontana E, Atgié C, Lafontan M, Berlan M: Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol. 1999, 359: 310-321. 10.1007/PL00005357.CrossRefPubMed Carpéné C, Galitzky J, Fontana E, Atgié C, Lafontan M, Berlan M: Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol. 1999, 359: 310-321. 10.1007/PL00005357.CrossRefPubMed
41.
go back to reference Sae-tan S, Grove KA, Lambert JD: Weight control and prevention of metabolic syndrome by green tea. Parmacol Res. 2011, 64: 146-154. Sae-tan S, Grove KA, Lambert JD: Weight control and prevention of metabolic syndrome by green tea. Parmacol Res. 2011, 64: 146-154.
42.
go back to reference Belza A, Toubro S, Astrup A: The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr. 2009, 63: 57-64. 10.1038/sj.ejcn.1602901.CrossRefPubMed Belza A, Toubro S, Astrup A: The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr. 2009, 63: 57-64. 10.1038/sj.ejcn.1602901.CrossRefPubMed
43.
go back to reference Maridakis V, Herring MP, O'Connor PJ: Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to differing doses of caffeine or breakfast. Int J Neurosci. 2009, 119: 975-994. 10.1080/00207450802333995.CrossRefPubMed Maridakis V, Herring MP, O'Connor PJ: Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to differing doses of caffeine or breakfast. Int J Neurosci. 2009, 119: 975-994. 10.1080/00207450802333995.CrossRefPubMed
44.
go back to reference Goldstein ER, Ziegenfuss T, Kalman D, Kreider R, Campbell B, Wilborn C, Taylor L, Willoughby D, Stout J, Graves BS, Wildman R, Ivy JL, Spano M, Smith AE, Antonio J: International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr. 2010, 7: 5-10.1186/1550-2783-7-5.PubMedCentralCrossRefPubMed Goldstein ER, Ziegenfuss T, Kalman D, Kreider R, Campbell B, Wilborn C, Taylor L, Willoughby D, Stout J, Graves BS, Wildman R, Ivy JL, Spano M, Smith AE, Antonio J: International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr. 2010, 7: 5-10.1186/1550-2783-7-5.PubMedCentralCrossRefPubMed
45.
go back to reference Hursel R, Westerterp-Plantenga MS: Thermogenic ingredients and body weight regulation. Int J Obes (Lond). 2010, 34: 659-669. 10.1038/ijo.2009.299.CrossRef Hursel R, Westerterp-Plantenga MS: Thermogenic ingredients and body weight regulation. Int J Obes (Lond). 2010, 34: 659-669. 10.1038/ijo.2009.299.CrossRef
46.
go back to reference Ahnis A, Riedl A, Figura A, Steinhagen-Thiessen E, Liebl ME, Klapp BF: Psychological and sociodemographic predictors of premature discontinuation of a 1-year multimodal outpatient weight-reduction program: an attrition analysis. Patient Prefer Adherence. 2012, 6: 165-177.PubMedCentralCrossRefPubMed Ahnis A, Riedl A, Figura A, Steinhagen-Thiessen E, Liebl ME, Klapp BF: Psychological and sociodemographic predictors of premature discontinuation of a 1-year multimodal outpatient weight-reduction program: an attrition analysis. Patient Prefer Adherence. 2012, 6: 165-177.PubMedCentralCrossRefPubMed
47.
go back to reference Inelmen EM, Toffanello ED, Enzi G, Gasparini G, Miotto F, Sergi G, Busetto L: Predictors of drop-out in overweight and obese outpatients. Int J Obes (Lond). 2005, 29 (1): 122-128. 10.1038/sj.ijo.0802846.CrossRef Inelmen EM, Toffanello ED, Enzi G, Gasparini G, Miotto F, Sergi G, Busetto L: Predictors of drop-out in overweight and obese outpatients. Int J Obes (Lond). 2005, 29 (1): 122-128. 10.1038/sj.ijo.0802846.CrossRef
48.
go back to reference Black AE, Prentice AM, Goldberg GR, Jebb SA, Bingham SA, Livingstone MB, Coward WA: Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake. J Am Diet Assoc. 1993, 93: 572-579. 10.1016/0002-8223(93)91820-G.CrossRefPubMed Black AE, Prentice AM, Goldberg GR, Jebb SA, Bingham SA, Livingstone MB, Coward WA: Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake. J Am Diet Assoc. 1993, 93: 572-579. 10.1016/0002-8223(93)91820-G.CrossRefPubMed
49.
go back to reference Keophiphath M, Priem F, Jacquemond-Collet I, Clément K, Lacasa D: 1,2-vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. J Nutr. 2009, 139 (11): 2055-2060. 10.3945/jn.109.105452.CrossRefPubMed Keophiphath M, Priem F, Jacquemond-Collet I, Clément K, Lacasa D: 1,2-vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. J Nutr. 2009, 139 (11): 2055-2060. 10.3945/jn.109.105452.CrossRefPubMed
50.
go back to reference Sahebkar A: Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol. 2011, 14 (2): 271-272.CrossRef Sahebkar A: Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol. 2011, 14 (2): 271-272.CrossRef
51.
go back to reference Albarracin CA, Fuqua BC, Evans JL, Goldfine ID: Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2008, 24 (1): 41-51. 10.1002/dmrr.755.CrossRefPubMed Albarracin CA, Fuqua BC, Evans JL, Goldfine ID: Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2008, 24 (1): 41-51. 10.1002/dmrr.755.CrossRefPubMed
Metadata
Title
Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women
Authors
Hector L Lopez
Tim N Ziegenfuss
Jennifer E Hofheins
Scott M Habowski
Shawn M Arent
Joseph P Weir
Arny A Ferrando
Publication date
01-12-2013
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-10-22

Other articles of this Issue 1/2013

Journal of the International Society of Sports Nutrition 1/2013 Go to the issue